Sangamo Therapeutics
SGMO
#10605
Rank
S$39.31 M
Marketcap
S$0.09489
Share price
0.00%
Change (1 day)
-85.72%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total debt

Total debt on the balance sheet as of March 2026 : S$24.78 Million

According to Sangamo Therapeutics 's latest financial reports the company's total debt is S$24.78 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Sangamo Therapeutics - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31S$34.4 M-17.2%
2024-12-31S$41.54 M-17.44%
2023-12-31S$50.32 M-12.92%
2022-12-31S$57.79 M-11.09%
2021-12-31S$65 M16.75%
2020-12-31S$55.67 M-7%
2019-12-31S$59.86 M58.26%
2018-12-31S$37.82 M14.33%
2017-12-31S$33.08 M479.5%
2016-12-31S$5.7 M
2015-12-31N/A
2001-12-31S$0.52 M
1999-12-31S$0.49 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$57.25 B 230,869.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$73.48 B 296,320.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$10.71 B 43,119.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$24.24 B 97,706.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$33.65 B 135,664.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$69.12 B 278,743.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.61 B 6,427.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$5.38 B 21,637.02%๐Ÿ‡บ๐Ÿ‡ธ USA